- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LENZ Therapeutics Inc (LENZ)
Track today's live LENZ Therapeutics (LENZ) share price, performance and key data on this page with our current NASDAQ:LENZ stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the LENZ Therapeutics share price on the NASDAQ exchange. Use the dropdown to switch exchange for the LENZ share price, head to our technical summary section, which provides analysis on LENZ Therapeutics share price buy/sell indicators using real-time data (or discuss the LENZ Therapeutics (LENZ) stock price today with other investors in the LENZ Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:LENZ share price (ISIN: US52635N1037) to enhance your trading decisions with our free investment tools and resources.
What Is the LENZ Therapeutics Inc Share Price Today?
The LENZ Therapeutics share price today is 3.05.
What Is the Stock Symbol for LENZ Therapeutics Inc
The stock symbol (or 'ticker') for LENZ Therapeutics Inc is "LENZ."
What Stock Exchange Does LENZ Therapeutics Inc Trade On?
LENZ Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is LENZ Therapeutics Inc a Good Stock to Buy?
Determining whether LENZ Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:LENZ share price (ISIN: US52635N1037) to enhance your trading decisions with our free investment tools and resources.
What Is the LENZ Therapeutics Inc Share Price Today?
The LENZ Therapeutics share price today is 3.05.
What Is the Stock Symbol for LENZ Therapeutics Inc
The stock symbol (or 'ticker') for LENZ Therapeutics Inc is "LENZ."
What Stock Exchange Does LENZ Therapeutics Inc Trade On?
LENZ Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is LENZ Therapeutics Inc a Good Stock to Buy?
Determining whether LENZ Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.04
3.43
52 wk Range
3.00
32.13
LENZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.043.43
52 wk Range
3.0032.13
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LENZ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
18.67
Upside
+512.02%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 8K LENZ Therapeutics Inc For: 28 October- Investing.com
Graphite Bio receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Graphite Bio receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 18.67
(+512.02% Upside)
LENZ Therapeutics Inc Earnings Call Summary for Q3/2026
- LENZ posted Q3 loss of $0.99/share vs. est. $0.91; revenue $3.38M missed forecast of $4.5M by 25%, though shares rose 2.8% to $3.30
- VIZZ product revenue jumped 50% sequentially to $2.6M; paid scripts climbed 51% to 38K+, with telehealth driving over half of new prescriptions
- Company announced major restructuring cutting operating expenses 50%+ to $70-75M in 2027, shifting 70%+ of spending to consumer marketing
- CEO Paddock steps down Dec. 1; CFO Chevallard becomes interim CEO as board searches for permanent replacement amid strategic pivot
- VIZZ holds 94% U.S. market share in presbyopia drops; 11 international regulatory submissions pending as company refocuses on direct-to-consumer model
Last Updated: 29/10/2026, 13:38
Read Full TranscriptEarnings
Latest Release
28/10/2026
EPS / Forecast
-0.99 / -0.91
Revenue / Forecast
3.38M / 4.5M
Compare LENZ to Peers and Sector
Metrics to compare | LENZ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLENZPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | 0.6x | −0.3x | |
PEG Ratio | 0.01 | −0.49 | 0.00 | |
Price/Book | 0.4x | 1.9x | 2.6x | |
Price / LTM Sales | 7.8x | 4.4x | 2.8x | |
Upside (Analyst Target) | - | 37.0% | 66.6% | |
Fair Value Upside | Unlock | 9.7% | 9.1% | Unlock |
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the LENZ Therapeutics (NASDAQ: LENZ) Share Price Today?
The LENZ Therapeutics stock price today is 3.05 USD.
What Stock Exchange Does LENZ Therapeutics (LENZ) Trade On?
LENZ Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for LENZ Therapeutics?
The stock symbol (also called a 'ticker') for LENZ Therapeutics is "LENZ."
What Is the Current LENZ Therapeutics Market Capitalisation?
As of today, LENZ Therapeutics (NASDAQ: LENZ) market cap is 109.66M USD.
What Is LENZ Therapeutics's (LENZ) Earnings Per Share (TTM)?
The LENZ Therapeutics EPS is currently -4.48 (Trailing Twelve Months).
When Is the Next LENZ Therapeutics Earnings Date?
LENZ Therapeutics's next earnings report will be released on 24/03/2027.
Is LENZ a Buy or Sell From a Technical Analyst Perspective?
Based on today's LENZ Therapeutics moving averages and other technical indicators, the daily buy/sell signal for LENZ stock is Strong Sell.
How Many Times Has LENZ Therapeutics Stock Split?
LENZ Therapeutics has split 1 times. (See the LENZ stock split history page for full effective split date and price information.)
How Many Employees Does LENZ Therapeutics Have?
LENZ Therapeutics has 152 employees, based on their latest Companies House report.
What is the current trading status of LENZ Therapeutics (NASDAQ: LENZ)?
As of 31/10/2026, LENZ Therapeutics (LENZ) is trading at a share price of 3.05 USD, with a previous close of 3.05 USD. The stock has fluctuated within a day range of 3.04 USD to 3.43 USD, while its 52-week range spans from 3.00 USD to 32.13 USD.
What Is LENZ Therapeutics (LENZ) Price Target According to Analysts?
The average 12-month price target for LENZ Therapeutics is 18.67 USD, with a high estimate of 45 USD and a low estimate of 4 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +512.02% Upside potential.
What Is the LENZ Premarket Price?
LENZ's last pre-market stock price is 3.21 USD. The pre-market share volume is 860.00, and the stock has decreased by -0.28, or -8.02%.
What Is the LENZ After Hours Price?
LENZ's last after hours stock price is 3.09 USD, the stock has decreased by 0.04, or 1.31%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.